• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

天然化合物作用于肝癌治疗新治疗药物靶点的研究进展

Recent Progress in Understanding the Action of Natural Compounds at Novel Therapeutic Drug Targets for the Treatment of Liver Cancer.

作者信息

Zheng Yannan, Zhang Wenhui, Xu Lin, Zhou Hua, Yuan Man, Xu Hongxi

机构信息

School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, China.

Engineering Research Center of Shanghai Colleges for Traditional Chinese Medicine (TCM) New Drug Discovery, Shanghai, China.

出版信息

Front Oncol. 2022 Jan 26;11:795548. doi: 10.3389/fonc.2021.795548. eCollection 2021.

DOI:10.3389/fonc.2021.795548
PMID:35155196
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8825370/
Abstract

Liver cancer is the third most common cause of cancer-related death following lung and stomach cancers. As a highly lethal disease, liver cancer is diagnosed frequently in less developed countries. Natural compounds extracted from herbs, animals and natural materials have been adopted by traditional Chinese medicine (TCM) practices and reported to be effective in the development of new medications for the treatment of diseases. It is important to focus on the mechanisms of action of natural compounds against hepatocellular carcinoma (HCC), particularly in terms of cell cycle regulation, apoptosis induction, autophagy mediation and cell migration and invasion. In this review, we characterize novel representative natural compounds according to their pharmacologic effects based on recently published studies. The aim of this review is to summarize and explore novel therapeutic drug targets of natural compounds, which could accelerate the discovery of new anticancer drugs.

摘要

肝癌是继肺癌和胃癌之后癌症相关死亡的第三大常见原因。作为一种高致死性疾病,肝癌在欠发达国家经常被诊断出来。从草药、动物和天然材料中提取的天然化合物已被中医实践所采用,并据报道在开发治疗疾病的新药物方面有效。关注天然化合物对肝细胞癌(HCC)的作用机制非常重要,特别是在细胞周期调控、凋亡诱导、自噬介导以及细胞迁移和侵袭方面。在本综述中,我们根据最近发表的研究,根据其药理作用对新型代表性天然化合物进行了表征。本综述的目的是总结和探索天然化合物的新型治疗药物靶点,这可能会加速新抗癌药物的发现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee63/8825370/55f6664ed659/fonc-11-795548-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee63/8825370/79de51aff705/fonc-11-795548-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee63/8825370/a3e9284e34b7/fonc-11-795548-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee63/8825370/d1f8c9bbc8fa/fonc-11-795548-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee63/8825370/55f6664ed659/fonc-11-795548-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee63/8825370/79de51aff705/fonc-11-795548-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee63/8825370/a3e9284e34b7/fonc-11-795548-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee63/8825370/d1f8c9bbc8fa/fonc-11-795548-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee63/8825370/55f6664ed659/fonc-11-795548-g004.jpg

相似文献

1
Recent Progress in Understanding the Action of Natural Compounds at Novel Therapeutic Drug Targets for the Treatment of Liver Cancer.天然化合物作用于肝癌治疗新治疗药物靶点的研究进展
Front Oncol. 2022 Jan 26;11:795548. doi: 10.3389/fonc.2021.795548. eCollection 2021.
2
Chinese herbal medicine-derived compounds for cancer therapy: a focus on hepatocellular carcinoma.中药来源的化合物在癌症治疗中的应用:以肝细胞癌为例。
J Ethnopharmacol. 2013 Oct 7;149(3):601-12. doi: 10.1016/j.jep.2013.07.030. Epub 2013 Aug 1.
3
Discovery of potential asthma targets based on the clinical efficacy of Traditional Chinese Medicine formulas.基于中药方剂临床疗效的潜在哮喘靶点的发现。
J Ethnopharmacol. 2020 Apr 24;252:112635. doi: 10.1016/j.jep.2020.112635. Epub 2020 Jan 28.
4
Uvangoletin, extracted from Sarcandra glabra, exerts anticancer activity by inducing autophagy and apoptosis and inhibiting invasion and migration on hepatocellular carcinoma cells.从九节龙中提取的乌檀木letin通过诱导自噬和凋亡以及抑制肝癌细胞的侵袭和迁移发挥抗癌活性。
Phytomedicine. 2022 Jan;94:153793. doi: 10.1016/j.phymed.2021.153793. Epub 2021 Oct 4.
5
Huanglian decoction suppresses the growth of hepatocellular carcinoma cells by reducing expression.黄连汤通过降低[具体表达内容]来抑制肝癌细胞的生长。 (原文中“reducing expression”缺少具体所指,翻译时保留英文以便理解完整意思)
World J Gastroenterol. 2021 Mar 14;27(10):939-958. doi: 10.3748/wjg.v27.i10.939.
6
Effects of adjuvant traditional Chinese medicine therapy on long-term survival in patients with hepatocellular carcinoma.辅助中药治疗对肝癌患者长期生存的影响。
Phytomedicine. 2019 Sep;62:152930. doi: 10.1016/j.phymed.2019.152930. Epub 2019 May 11.
7
Autophagy: A Potential Therapeutic Target of Polyphenols in Hepatocellular Carcinoma.自噬:多酚在肝细胞癌中的潜在治疗靶点
Cancers (Basel). 2020 Feb 29;12(3):562. doi: 10.3390/cancers12030562.
8
Can highly cited herbs in ancient Traditional Chinese medicine formulas and modern publications predict therapeutic targets for diabetes mellitus?古代中医药方剂和现代出版物中高引用的草药能否预测糖尿病的治疗靶点?
J Ethnopharmacol. 2018 Mar 1;213:101-110. doi: 10.1016/j.jep.2017.10.032. Epub 2017 Nov 2.
9
Alkaloids from Traditional Chinese Medicine against hepatocellular carcinoma.中药生物碱抗肝癌。
Biomed Pharmacother. 2019 Dec;120:109543. doi: 10.1016/j.biopha.2019.109543. Epub 2019 Oct 23.
10
Traditional Chinese medicine formulas for the treatment of osteoporosis: Implication for antiosteoporotic drug discovery.用于治疗骨质疏松症的中药方剂:对抗骨质疏松药物发现的启示。
J Ethnopharmacol. 2016 Aug 2;189:61-80. doi: 10.1016/j.jep.2016.05.025. Epub 2016 May 11.

引用本文的文献

1
Antitumor effects and mechanisms of traditional Chinese medicine gamboge: A review.中药藤黄的抗肿瘤作用及机制:综述
Front Pharmacol. 2025 Aug 18;16:1650560. doi: 10.3389/fphar.2025.1650560. eCollection 2025.
2
A review of six bioactive compounds from preclinical studies as potential breast cancer inhibitors.一项对临床前研究中六种作为潜在乳腺癌抑制剂的生物活性化合物的综述。
Mol Biol Rep. 2025 Feb 5;52(1):203. doi: 10.1007/s11033-025-10300-0.
3
Immunoregulatory Effects of Polysaccharide Modified Selenium Nanoparticles on H22 Tumor-Bearing Mice.

本文引用的文献

1
Efficacy and Safety of Ejiao (Asini Corii Colla) in Women With Blood Deficient Symptoms: A Randomized, Double-Blind, and Placebo-Controlled Clinical Trial.阿胶对血虚症状女性的疗效及安全性:一项随机、双盲、安慰剂对照临床试验
Front Pharmacol. 2021 Oct 11;12:718154. doi: 10.3389/fphar.2021.718154. eCollection 2021.
2
Puerarin Inhibits the PERK-eIF2[Formula: see text]-ATF4-CHOP Pathway through Inactivating JAK2/STAT3 Signal in Pancreatic beta-Cells.葛根素通过使胰腺β细胞中的JAK2/STAT3信号失活来抑制PERK-eIF2[公式:见正文]-ATF4-CHOP通路。
Am J Chin Med. 2021;49(7):1723-1738. doi: 10.1142/S0192415X21500816. Epub 2021 Sep 6.
3
多糖修饰的硒纳米颗粒对荷H22肿瘤小鼠的免疫调节作用
Foods. 2024 Dec 17;13(24):4073. doi: 10.3390/foods13244073.
4
Lactoferrin targeting INTL1 receptor inhibits hepatocellular carcinoma progression via apoptosis and cell cycle signaling pathways.靶向INTL1受体的乳铁蛋白通过凋亡和细胞周期信号通路抑制肝细胞癌进展。
Sci Rep. 2024 Dec 28;14(1):31210. doi: 10.1038/s41598-024-82514-4.
5
Mitoepigenetics pathways and natural compounds: a dual approach to combatting hepatocellular carcinoma.线粒体表观遗传学途径和天然化合物:双重方法对抗肝细胞癌。
Med Oncol. 2024 Oct 27;41(12):302. doi: 10.1007/s12032-024-02538-8.
6
From traditional Chinese medicine formulations to effective anticancer agents: Insights from Calculus bovis.从中药方剂到有效的抗癌药物:从牛 calculus 中获得的启示。
World J Gastroenterol. 2024 Sep 21;30(35):4011-4013. doi: 10.3748/wjg.v30.i35.4011.
7
Progress of natural sesquiterpenoids in the treatment of hepatocellular carcinoma.天然倍半萜类化合物在肝细胞癌治疗中的研究进展
Front Oncol. 2024 Jul 16;14:1445222. doi: 10.3389/fonc.2024.1445222. eCollection 2024.
8
Advancements in Utilizing Natural Compounds for Modulating Autophagy in Liver Cancer: Molecular Mechanisms and Therapeutic Targets.利用天然化合物调控肝癌自噬的研究进展:分子机制和治疗靶点。
Cells. 2024 Jul 12;13(14):1186. doi: 10.3390/cells13141186.
9
Therapeutic Effects of Natural Products on Liver Cancer and Their Potential Mechanisms.天然产物对肝癌的治疗作用及其潜在机制。
Nutrients. 2024 May 27;16(11):1642. doi: 10.3390/nu16111642.
10
A comprehensive review of phytoconstituents in liver cancer prevention and treatment: targeting insights into molecular signaling pathways.肝癌防治中植物成分的综合述评:靶向分子信号通路的见解。
Med Oncol. 2024 May 4;41(6):134. doi: 10.1007/s12032-024-02333-5.
Peroxiredoxin 1 is essential for natamycin-triggered apoptosis and protective autophagy in hepatocellular carcinoma.
过氧化物还原酶1对纳他霉素引发的肝癌细胞凋亡和保护性自噬至关重要。
Cancer Lett. 2021 Aug 21;521:210-223. doi: 10.1016/j.canlet.2021.08.023.
4
Gut microbiota enhances the chemosensitivity of hepatocellular carcinoma to 5-fluorouracil in vivo by increasing curcumin bioavailability.肠道微生物群通过增加姜黄素的生物利用度来增强体内肝癌对 5-氟尿嘧啶的化疗敏感性。
Phytother Res. 2021 Oct;35(10):5823-5837. doi: 10.1002/ptr.7240. Epub 2021 Aug 10.
5
Treatment for liver cancer: From sorafenib to natural products.肝癌治疗:从索拉非尼到天然产物。
Eur J Med Chem. 2021 Nov 15;224:113690. doi: 10.1016/j.ejmech.2021.113690. Epub 2021 Jul 5.
6
Iso-suillin-induced DNA damage leading to cell cycle arrest and apoptosis arised from p53 phosphorylation in A549 cells.异硫脲诱导的 DNA 损伤导致 A549 细胞中 p53 磷酸化引起的细胞周期停滞和细胞凋亡。
Eur J Pharmacol. 2021 Sep 15;907:174299. doi: 10.1016/j.ejphar.2021.174299. Epub 2021 Jul 1.
7
Novel CDK9 inhibitor oroxylin A promotes wild-type P53 stability and prevents hepatocellular carcinoma progression by disrupting both MDM2 and SIRT1 signaling.新型 CDK9 抑制剂山奈酚通过破坏 MDM2 和 SIRT1 信号通路促进野生型 P53 稳定性并防止肝细胞癌进展。
Acta Pharmacol Sin. 2022 Apr;43(4):1033-1045. doi: 10.1038/s41401-021-00708-2. Epub 2021 Jun 29.
8
Autophagy Regulates Stress Responses, Metabolism, and Anticancer Immunity.自噬调节应激反应、代谢和抗癌免疫。
Trends Cancer. 2021 Aug;7(8):778-789. doi: 10.1016/j.trecan.2021.05.003. Epub 2021 Jun 7.
9
Graphene Oxide Loaded with Protocatechuic Acid and Chlorogenic Acid Dual Drug Nanodelivery System for Human Hepatocellular Carcinoma Therapeutic Application.载原儿茶酸和绿原酸的氧化石墨烯双重药物纳米递药系统用于人肝癌的治疗应用。
Int J Mol Sci. 2021 May 28;22(11):5786. doi: 10.3390/ijms22115786.
10
PNO1 regulates autophagy and apoptosis of hepatocellular carcinoma via the MAPK signaling pathway.PNO1 通过 MAPK 信号通路调节肝癌细胞的自噬和凋亡。
Cell Death Dis. 2021 May 28;12(6):552. doi: 10.1038/s41419-021-03837-y.